NYSE · Asset Management · USD

BlackRock Health Sciences Trust (BME) Stock Analysis

BlackRock Health Sciences Trust (BME) is a Asset Management stock listed on NYSE and quoted in US Dollar.

BME

$45.81

−$0.20 (−0.43%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BME with… →

BME Key Statistics

As of Sep 4, 2026

Trading

Open: $45.63
Previous Close: $46.01
Day's Range: 45.50–45.97
52-Week Range: 35.95–46.43
Volume: 35.30K

Valuation

P/E Ratio: 7.74
EPS (ttm): 5.92

Financials (FY)

Revenue (FY): $77.54M+222.10%
Net Income (FY): $76.97M+228.16%
Profit margin: 1371.16%
1-Year Return: +33.50%

Dividend and dates

Dividend: $3.15+6.87%
Ex-Dividend Date: September 15, 2026
Avg Volume: 45.56K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

BME Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−6.77%+24.04%+16.49%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	+16.49%
2025	+17.86%
2024	−0.08%
2023	−1.08%
2022	−4.62%
2021	+7.25%
2020	+18.64%
2019	+24.04%
2018	+6.38%
2017	+23.10%
2016 (partial year)	−6.77%

As of September 4, 2026.

BME Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$77.54M	$76.97M	99.3%
2024	$24.07M	$23.45M	97.4%
2023	$20.41M	$20.02M	98.1%
2022	−$25.97M	−$26.47M	101.9%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$77.54M	—	—	$76.97M	99.3%
2024	$24.07M	—	—	$23.45M	97.4%
2023	$20.41M	—	—	$20.02M	98.1%
2022	−$25.97M	—	—	−$26.47M	101.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

BME Dividend History

’16’17’18’19’20’21’22’23’24’25’26*

$3.14+20.7% vs 2024

Dividends per share, 2025 · 12 payments

Year	Dividends per share	Payments	Change
2026*	$2.10	8	—
2025	$3.14	12	+20.7%
2024	$2.61	12	+1.9%
2023	$2.56	12	+0.0%

Year	Dividends per share	Payments	Change
2026 (partial year)	$2.10	8	—
2025	$3.14	12	+20.7%
2024	$2.61	12	+1.9%
2023	$2.56	12	+0.0%
2022	$2.56	12	+4.8%
2021	$2.44	12	+1.6%
2020	$2.40	12	+0.0%
2019	$2.40	12	+0.0%
2018	$2.40	12	+0.0%
2017	$2.40	12	+71.4%
2016	$1.40	4	—

Most recent payment: $0.26 per share, ex-dividend August 14, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

BME Valuation vs Asset Management Median

Median of 561 stocks

Metric	BME	Asset Management median	vs median
P/E	7.74	10.34	25% below
Profit margin	1371.16%	24.09%	1347.1 pts above

Medians across 561 Asset Management stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The record here covers BlackRock Health Sciences Trust, ticker BME. The company sits in the Financial Services sector, in the Asset Management industry.

Over the past 52 weeks the price has ranged from $35.95 to $46.43. The most recent close on file for BME is $45.81, dated September 4, 2026. That is −$0.20 (−0.43%) against the previous close. The latest close sits 27.43% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $77.54M. Against the prior fiscal year total of $24.07M, that is a change of +222.10%. Net income for the same year was $76.97M. That is +228.16% against the prior fiscal year. Profit margin runs at 1,371.16%. That is 1,347.1 percentage points above the Asset Management median of 24.09%. Earnings per share on a trailing basis come to 5.92.

Across the 4 fiscal years on file, revenue moves from −$25.97M in 2022 to $77.54M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

BME trades at a trailing price-to-earnings ratio of 7.74. That is 25.15% below the Asset Management median of 10.34. 561 Asset Management companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is +33.50%. Measured over 10 years, that is +9.91% a year compounded. Daily returns over the trailing 10 years annualize to a volatility of 19.82%.

Growth & Income

BME pays a dividend yielding 6.87%. That is 1.2 percentage points below the Asset Management median yield of 8.11%. The indicated annual rate is $3.15 a share. The ex-dividend date on file is September 15, 2026. Dividends are recorded for 11 calendar years; 2026 shows 8 payments totalling $2.10 a share. The year before, 2025, totalled $3.14 a share.

Across the complete calendar years on file, 2019 returned +24.04% and 2022 returned −4.62%. Of the 9 complete calendar years on file, 6 finished higher. So far in 2026 the price is +16.49%.

Peer Comparison

BlackRock Health Sciences Trust (BME) operates in the Asset Management industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
BlackRock Health Sciences Trust	BME	—	7.7
BlackRock, Inc.	BLK	$182.35B	26.9
Blackstone Inc.	BX	$162.74B	30.5
KKR & Co. Inc.	KKR	$99.50B	34.4

The Asset Management industry average P/E ratio is 10.3x. BlackRock Health Sciences Trust trades at a P/E of 7.7.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Asset Management Stocks

BLK

BlackRock, Inc.

$182.35B

Blackstone Inc.

$162.74B

KKR

KKR & Co. Inc.

$99.50B

Brookfield Corporation

$89.99B

BAM

Brookfield Asset Management Ltd.

$80.82B

APO

Apollo Global Management, Inc.

$78.94B

View all Asset Management stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Visit website →